Sectors
PHIO
Phio Pharmaceuticals Corp.
1.10
3 x 1.10
10 x 1.11
bid
ask
-
0.02
2.21%
10:01 AM
timesize
| Ytd | 5.24% | |
| 1y | -56.15% |
1.11
day range
1.13
0.81
52 week range
4.19
| Open | 1.12 | Prev Close | 1.13 | Low | 1.11 | High | 1.13 | Mkt Cap | 13.13M |
| Vol | 63.11K | Avg Vol | 616.37K | EPS | -1.38 | P/E | -0.82 | Forward P/E | 0.07 |
| Beta | 0.81 | Short Ratio | 0.50 | Inst. Own | 3.02% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 1.06 | 200-d Avg | 1.27 | 1yr Est | 36.00 |
| Income Statement | |||
| Operating Expenses | 4.17M | ||
| Research and Development Expense | 2.79M | ||
| Selling, General and Administrative Expense | 1.37M | ||
| Operating Income | -4.17M | ||
| Net Income | -4.00M | ||
| Net Income Common Stock | -4.00M | ||
| Net Income Common Stock (USD) | -4.00M | ||
| Consolidated Income | -4.00M | ||
| Earnings per Basic Share | -0.34 | ||
| Earnings per Basic Share (USD) | -0.34 | ||
| Earnings per Diluted Share | -0.34 | ||
| Earning Before Interest & Taxes (EBIT) | -4.00M | ||
| Earning Before Interest & Taxes (USD) | -4.00M | ||
| Weighted Average Shares | 11.62M | ||
| Weighted Average Shares Diluted | 11.62M | ||
| Balance Sheet | |||
| Cash and Equivalents | 17.03M | ||
| Cash and Equivalents (USD) | 17.03M | ||
| Current Assets | 17.40M | ||
| Property, Plant & Equipment Net | 10.00K | ||
| Total Assets | 17.41M | ||
| Current Liabilities | 950.00K | ||
| Total Liabilities | 950.00K | ||
| Accumulated Retained Earnings (Deficit) | -159.06M | ||
| Shareholders Equity | 16.46M | ||
| Shareholders Equity (USD) | 16.46M | ||
| Assets Non-Current | 10.00K | ||
| Trade and Non-Trade Payables | 260.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1000 | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -4.00M | ||
| Net Cash Flow - Business Acquisitions and Disposals | 3.00K | ||
| Net Cash Flow from Investing | 3.00K | ||
| Net Cash Flow from Operations | -4.00M | ||
| Share Based Compensation | 318.00K | ||